The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days

Background: Never before have clinical trials drawn as much public attention as those testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical research response and its evolution over the first 100 days of the pandemic. Methods: Descriptive analysis of planned, ongoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Janiaud, Perrine, Axfors, Cathrine, van't Hooft, Janneke, Saccilotto, Ramon, Agarwal, Arnav, Appenzeller-Herzog, Christian, Contopoulos-Ioannidis, Despina G., Danchev, Valentin, Dirnagl, Ulrich, Ewald, Hannah, Gartlehner, Gerald, Goodman, Steven N., Haber, Noah A., Ioannidis, Angeliki Diotima, Ioannidis, John P. A., Lythgoe, Mark P., Ma, Wenyan, Macleod, Malcolm, Malički, Mario, Meerpohl, Joerg J., Min, Yan, Moher, David, Nagavci, Blin, Naudet, Florian, Pauli-Magnus, Christiane, O'Sullivan, Jack W., Riedel, Nico, Roth, Jan A., Sauermann, Mandy, Schandelmaier, Stefan, Schmitt, Andreas M., Speich, Benjamin, Williamson, Paula R., Hemkens, Lars G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539080/
https://www.ncbi.nlm.nih.gov/pubmed/33082937
http://dx.doi.org/10.12688/f1000research.26707.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539080/
https://www.ncbi.nlm.nih.gov/pubmed/33082937
http://dx.doi.org/10.12688/f1000research.26707.2

Ejemplares similares